

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular extravasation (GO:0045123) | 6.19097754 |
| 2 | neutrophil mediated immunity (GO:0002446) | 6.04823898 |
| 3 | response to peptidoglycan (GO:0032494) | 5.86709358 |
| 4 | leukocyte aggregation (GO:0070486) | 5.70204208 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.67737243 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.67737243 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.67737243 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.67737243 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.67737243 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.67737243 |
| 11 | macrophage differentiation (GO:0030225) | 5.50100896 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.45117696 |
| 13 | respiratory burst (GO:0045730) | 5.39342275 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.33498593 |
| 15 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.33183726 |
| 16 | defense response to fungus (GO:0050832) | 5.09684425 |
| 17 | response to host immune response (GO:0052572) | 5.01545489 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 5.01545489 |
| 19 | detection of molecule of bacterial origin (GO:0032490) | 4.94928618 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.87896095 |
| 21 | detection of external biotic stimulus (GO:0098581) | 4.86800451 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.85948034 |
| 23 | neutrophil activation (GO:0042119) | 4.80375480 |
| 24 | response to fungus (GO:0009620) | 4.75012602 |
| 25 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.74008255 |
| 26 | response to host (GO:0075136) | 4.74008255 |
| 27 | response to host defenses (GO:0052200) | 4.74008255 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.72685291 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.66914785 |
| 30 | response to interleukin-15 (GO:0070672) | 4.59948660 |
| 31 | myeloid leukocyte mediated immunity (GO:0002444) | 4.56548511 |
| 32 | negative regulation of phagocytosis (GO:0050765) | 4.54349875 |
| 33 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.53782183 |
| 34 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.53782183 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 4.47560306 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.44124413 |
| 37 | negative regulation of cell killing (GO:0031342) | 4.44124413 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 4.43261827 |
| 39 | granulocyte activation (GO:0036230) | 4.42082124 |
| 40 | negative regulation of granulocyte differentiation (GO:0030853) | 4.41890532 |
| 41 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.26278626 |
| 42 | detection of biotic stimulus (GO:0009595) | 4.24495426 |
| 43 | microglial cell activation (GO:0001774) | 4.21316487 |
| 44 | regulation of mast cell activation (GO:0033003) | 4.19511078 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 4.16391292 |
| 46 | negative regulation of interleukin-12 production (GO:0032695) | 4.11972616 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 4.11634258 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.09965393 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 4.08269179 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06465875 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.05637377 |
| 52 | regulation of B cell differentiation (GO:0045577) | 4.02418172 |
| 53 | regulation of gamma-delta T cell activation (GO:0046643) | 3.99722519 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.92816908 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.91764815 |
| 56 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.91566626 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.90753136 |
| 58 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.84835409 |
| 59 | detection of other organism (GO:0098543) | 3.79104959 |
| 60 | myeloid cell activation involved in immune response (GO:0002275) | 3.78917071 |
| 61 | regulation of leukocyte degranulation (GO:0043300) | 3.76724607 |
| 62 | * neutrophil chemotaxis (GO:0030593) | 3.65622118 |
| 63 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.63499599 |
| 64 | type I interferon signaling pathway (GO:0060337) | 3.60910310 |
| 65 | cellular response to type I interferon (GO:0071357) | 3.60910310 |
| 66 | response to type I interferon (GO:0034340) | 3.58333175 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 3.55326033 |
| 68 | * neutrophil migration (GO:1990266) | 3.54596567 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.53449358 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.53151249 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.52984252 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.52971270 |
| 73 | response to muramyl dipeptide (GO:0032495) | 3.52329603 |
| 74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.52091660 |
| 75 | positive regulation of antigen processing and presentation (GO:0002579) | 3.51487965 |
| 76 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.50657335 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.50657335 |
| 78 | detection of bacterium (GO:0016045) | 3.49787620 |
| 79 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.48397399 |
| 80 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.48397399 |
| 81 | reactive oxygen species biosynthetic process (GO:1903409) | 3.47217121 |
| 82 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.42081307 |
| 83 | negative regulation of interleukin-6 production (GO:0032715) | 3.40159936 |
| 84 | positive regulation of mast cell degranulation (GO:0043306) | 3.36721368 |
| 85 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.36721368 |
| 86 | regulation of T cell tolerance induction (GO:0002664) | 3.36271800 |
| 87 | macrophage activation (GO:0042116) | 3.35448532 |
| 88 | defense response to protozoan (GO:0042832) | 3.34661603 |
| 89 | leukotriene metabolic process (GO:0006691) | 3.33374564 |
| 90 | B cell mediated immunity (GO:0019724) | 3.31220209 |
| 91 | regulation of tolerance induction (GO:0002643) | 3.29096341 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.28769834 |
| 93 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.27847696 |
| 94 | superoxide anion generation (GO:0042554) | 3.27518302 |
| 95 | killing of cells of other organism (GO:0031640) | 3.26937556 |
| 96 | disruption of cells of other organism (GO:0044364) | 3.26937556 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23757065 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23427275 |
| 99 | positive regulation of interferon-alpha production (GO:0032727) | 3.20086015 |
| 100 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.19731714 |
| 101 | leukocyte mediated cytotoxicity (GO:0001909) | 3.19286988 |
| 102 | negative regulation of type 2 immune response (GO:0002829) | 3.19025245 |
| 103 | B cell receptor signaling pathway (GO:0050853) | 3.18876661 |
| 104 | response to protozoan (GO:0001562) | 3.15823881 |
| 105 | regulation of regulated secretory pathway (GO:1903305) | 3.15377724 |
| 106 | leukocyte degranulation (GO:0043299) | 3.12886934 |
| 107 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.09495634 |
| 108 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.08391314 |
| 109 | leukocyte cell-cell adhesion (GO:0007159) | 3.07980680 |
| 110 | dendritic cell chemotaxis (GO:0002407) | 3.04812179 |
| 111 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.03755263 |
| 112 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.03755263 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.03701141 |
| 114 | germinal center formation (GO:0002467) | 3.03698139 |
| 115 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02870742 |
| 116 | negative regulation of innate immune response (GO:0045824) | 3.02375534 |
| 117 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.01841499 |
| 118 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.01841499 |
| 119 | regulation of growth of symbiont in host (GO:0044126) | 3.01841499 |
| 120 | negative regulation of growth of symbiont in host (GO:0044130) | 3.01841499 |
| 121 | regulation of interferon-alpha production (GO:0032647) | 3.00891053 |
| 122 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00890161 |
| 123 | myeloid leukocyte activation (GO:0002274) | 3.00284313 |
| 124 | * granulocyte migration (GO:0097530) | 3.00214470 |
| 125 | * granulocyte chemotaxis (GO:0071621) | 3.00137845 |
| 126 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.97966969 |
| 127 | leukotriene biosynthetic process (GO:0019370) | 2.96928946 |
| 128 | adaptation of signaling pathway (GO:0023058) | 2.96233267 |
| 129 | negative regulation of mast cell activation (GO:0033004) | 2.95745529 |
| 130 | dendritic cell migration (GO:0036336) | 2.94579916 |
| 131 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94235018 |
| 132 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92395199 |
| 133 | positive regulation of chemokine secretion (GO:0090197) | 2.91710374 |
| 134 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.91035909 |
| 135 | regulation of antigen processing and presentation (GO:0002577) | 2.90247891 |
| 136 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.89946599 |
| 137 | mature B cell differentiation (GO:0002335) | 2.87182409 |
| 138 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.85108927 |
| 139 | regulation of phagocytosis (GO:0050764) | 2.84256522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.82521661 |
| 2 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.30058485 |
| 3 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 4.23883817 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.23680311 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.87670494 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.83164316 |
| 7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.74445194 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.66546551 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.50890714 |
| 10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.47601026 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.34426422 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.05074512 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.04064471 |
| 14 | SPI1_23547873_ChIP-Seq_NB4_Human | 3.01715704 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.99304960 |
| 16 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.85123123 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71895101 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.54215374 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.50356087 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.43279407 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.40217797 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31493582 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.30446729 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.30206647 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.29605620 |
| 26 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.27362545 |
| 27 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23934073 |
| 28 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23134646 |
| 29 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14772129 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 2.09739033 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.07530748 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.04279540 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01894656 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.01159614 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.96470989 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.96282163 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.95408021 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94983165 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.90769598 |
| 40 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84276983 |
| 41 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82941226 |
| 42 | UTX_26944678_Chip-Seq_JUKART_Human | 1.82630072 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.81806858 |
| 44 | * MYB_26560356_Chip-Seq_TH1_Human | 1.78467044 |
| 45 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.75464784 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64825044 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63820501 |
| 48 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63559050 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59572711 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.58383782 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55684230 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.55511630 |
| 53 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55017501 |
| 54 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.54864502 |
| 55 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.54848768 |
| 56 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.50329158 |
| 57 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47343246 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42993042 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.42940550 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36539512 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36133954 |
| 62 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34574417 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31633019 |
| 64 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31285501 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29146803 |
| 66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28197459 |
| 67 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27096849 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.24764171 |
| 69 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24534045 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23498265 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23295755 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22666878 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21501065 |
| 74 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21019740 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20327692 |
| 76 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19497608 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 1.18305417 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16975211 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16030572 |
| 80 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.14499646 |
| 81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14302093 |
| 82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13700862 |
| 83 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13128995 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12357398 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11754608 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11373541 |
| 87 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.09728485 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07900990 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05999223 |
| 90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.05317975 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.01427863 |
| 92 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01155370 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00281380 |
| 94 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00114854 |
| 95 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.99843933 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99777712 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98337042 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.98190083 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93880189 |
| 100 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.88169679 |
| 101 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86340545 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.85592314 |
| 103 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84927598 |
| 104 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.82586853 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80818562 |
| 106 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79847153 |
| 107 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78464057 |
| 108 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.75440040 |
| 109 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.73931301 |
| 110 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73102255 |
| 111 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.70572396 |
| 112 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.70271918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.09652194 |
| 2 | MP0009278_abnormal_bone_marrow | 3.82802843 |
| 3 | MP0003303_peritoneal_inflammation | 3.52860269 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.26982182 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.22723677 |
| 6 | MP0009785_altered_susceptibility_to | 3.13643874 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.85064611 |
| 8 | MP0003183_abnormal_peptide_metabolism | 2.73133796 |
| 9 | MP0005025_abnormal_response_to | 2.67237073 |
| 10 | MP0001545_abnormal_hematopoietic_system | 2.65909060 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.65909060 |
| 12 | MP0001853_heart_inflammation | 2.50775537 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.49915555 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.44332496 |
| 15 | MP0005671_abnormal_response_to | 2.43348720 |
| 16 | MP0003724_increased_susceptibility_to | 2.42944687 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.41050932 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.39285991 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.37934417 |
| 20 | MP0001800_abnormal_humoral_immune | 2.29706818 |
| 21 | MP0001533_abnormal_skeleton_physiology | 2.22458861 |
| 22 | MP0002723_abnormal_immune_serum | 2.21718624 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 2.21679431 |
| 24 | * MP0001819_abnormal_immune_cell | 2.21415244 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 2.20905814 |
| 26 | MP0000685_abnormal_immune_system | 2.17434059 |
| 27 | MP0000465_gastrointestinal_hemorrhage | 2.16600862 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 2.15419455 |
| 29 | * MP0002396_abnormal_hematopoietic_system | 2.13508506 |
| 30 | MP0000343_altered_response_to | 2.12884854 |
| 31 | MP0003075_altered_response_to | 2.10614767 |
| 32 | MP0002405_respiratory_system_inflammati | 2.01138092 |
| 33 | MP0006082_CNS_inflammation | 1.99019610 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.95637994 |
| 35 | MP0005387_immune_system_phenotype | 1.94572788 |
| 36 | MP0001790_abnormal_immune_system | 1.94572788 |
| 37 | MP0001845_abnormal_inflammatory_respons | 1.77704224 |
| 38 | * MP0002398_abnormal_bone_marrow | 1.77017088 |
| 39 | * MP0000716_abnormal_immune_system | 1.73995875 |
| 40 | * MP0004808_abnormal_hematopoietic_stem | 1.72891211 |
| 41 | MP0001851_eye_inflammation | 1.70723439 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.67464351 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.62123270 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.59067134 |
| 45 | MP0005451_abnormal_body_composition | 1.58002851 |
| 46 | MP0004381_abnormal_hair_follicle | 1.57920605 |
| 47 | MP0000858_altered_metastatic_potential | 1.57201860 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.52401428 |
| 49 | MP0009764_decreased_sensitivity_to | 1.50537239 |
| 50 | MP0002837_dystrophic_cardiac_calcinosis | 1.50456150 |
| 51 | MP0008469_abnormal_protein_level | 1.49209648 |
| 52 | * MP0002429_abnormal_blood_cell | 1.49201744 |
| 53 | MP0002933_joint_inflammation | 1.47940091 |
| 54 | MP0004883_abnormal_blood_vessel | 1.45970372 |
| 55 | MP0002722_abnormal_immune_system | 1.45682837 |
| 56 | MP0004510_myositis | 1.38130899 |
| 57 | MP0002166_altered_tumor_susceptibility | 1.35875258 |
| 58 | MP0001873_stomach_inflammation | 1.35402996 |
| 59 | MP0003828_pulmonary_edema | 1.34790840 |
| 60 | MP0003279_aneurysm | 1.32991765 |
| 61 | MP0005023_abnormal_wound_healing | 1.30005091 |
| 62 | MP0004947_skin_inflammation | 1.28533705 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.28319443 |
| 64 | MP0005166_decreased_susceptibility_to | 1.27750597 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.25971229 |
| 66 | MP0009840_abnormal_foam_cell | 1.24705460 |
| 67 | MP0003448_altered_tumor_morphology | 1.22870502 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.22211625 |
| 69 | MP0000490_abnormal_crypts_of | 1.16737119 |
| 70 | MP0005164_abnormal_response_to | 1.07245080 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.02308273 |
| 72 | MP0002006_tumorigenesis | 0.98868027 |
| 73 | MP0005390_skeleton_phenotype | 0.98564872 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.96769477 |
| 75 | MP0003878_abnormal_ear_physiology | 0.96680337 |
| 76 | MP0005377_hearing/vestibular/ear_phenot | 0.96680337 |
| 77 | MP0000703_abnormal_thymus_morphology | 0.94735500 |
| 78 | MP0003866_abnormal_defecation | 0.93141229 |
| 79 | MP0003763_abnormal_thymus_physiology | 0.92595109 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.90476389 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.90057898 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.88623021 |
| 83 | MP0003693_abnormal_embryo_hatching | 0.87435604 |
| 84 | MP0008004_abnormal_stomach_pH | 0.87053427 |
| 85 | MP0008260_abnormal_autophagy | 0.85455786 |
| 86 | MP0001764_abnormal_homeostasis | 0.83958066 |
| 87 | MP0002928_abnormal_bile_duct | 0.82778533 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.81852329 |
| 89 | MP0000249_abnormal_blood_vessel | 0.81696610 |
| 90 | MP0003045_fibrosis | 0.79394879 |
| 91 | MP0009763_increased_sensitivity_to | 0.79091014 |
| 92 | MP0004858_abnormal_nervous_system | 0.75951089 |
| 93 | MP0010307_abnormal_tumor_latency | 0.74616508 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.74448590 |
| 95 | MP0000371_diluted_coat_color | 0.73528945 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.73085048 |
| 97 | MP0005310_abnormal_salivary_gland | 0.72348488 |
| 98 | MP0002019_abnormal_tumor_incidence | 0.69877156 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.68772919 |
| 100 | MP0001663_abnormal_digestive_system | 0.67880940 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.67770572 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.64488487 |
| 103 | MP0005248_abnormal_Harderian_gland | 0.64029822 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.63874844 |
| 105 | MP0008874_decreased_physiological_sensi | 0.62514857 |
| 106 | MP0002132_abnormal_respiratory_system | 0.60443372 |
| 107 | MP0003795_abnormal_bone_structure | 0.60119304 |
| 108 | MP0004130_abnormal_muscle_cell | 0.60055549 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.58382467 |
| 110 | MP0001958_emphysema | 0.58220561 |
| 111 | MP0003690_abnormal_glial_cell | 0.57648254 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.56979834 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.56467548 |
| 114 | MP0000604_amyloidosis | 0.56465021 |
| 115 | MP0005388_respiratory_system_phenotype | 0.56420606 |
| 116 | MP0002133_abnormal_respiratory_system | 0.56420606 |
| 117 | MP0010352_gastrointestinal_tract_polyps | 0.56291193 |
| 118 | MP0000920_abnormal_myelination | 0.55284465 |
| 119 | MP0002138_abnormal_hepatobiliary_system | 0.52921938 |
| 120 | MP0003252_abnormal_bile_duct | 0.52257498 |
| 121 | MP0005083_abnormal_biliary_tract | 0.50353270 |
| 122 | MP0002693_abnormal_pancreas_physiology | 0.49844883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.91814733 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.02592589 |
| 3 | Eczematoid dermatitis (HP:0000976) | 6.88670472 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.03376928 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 5.37566222 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.09703212 |
| 7 | Gastrointestinal infarctions (HP:0005244) | 4.81082545 |
| 8 | Obstructive lung disease (HP:0006536) | 4.61794457 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.61794457 |
| 10 | Myositis (HP:0100614) | 4.56948511 |
| 11 | Recurrent skin infections (HP:0001581) | 4.31962299 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12098565 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.11428926 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.09009245 |
| 15 | Keratoconjunctivitis (HP:0001096) | 3.95965430 |
| 16 | Gingivitis (HP:0000230) | 3.93549796 |
| 17 | Hypochromic microcytic anemia (HP:0004840) | 3.81050706 |
| 18 | Glomerulonephritis (HP:0000099) | 3.78207321 |
| 19 | Increased cerebral lipofuscin (HP:0011813) | 3.71750095 |
| 20 | Cellulitis (HP:0100658) | 3.66587465 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.63573987 |
| 22 | Stomatitis (HP:0010280) | 3.62982226 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.58109736 |
| 24 | Episodic fever (HP:0001954) | 3.50965444 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 3.48336311 |
| 26 | Hypochromic anemia (HP:0001931) | 3.47574626 |
| 27 | Peritonitis (HP:0002586) | 3.44087674 |
| 28 | Orchitis (HP:0100796) | 3.39464498 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.33502956 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.33502956 |
| 31 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.33502956 |
| 32 | Meningitis (HP:0001287) | 3.29487435 |
| 33 | Urticaria (HP:0001025) | 3.17484285 |
| 34 | Prolonged bleeding time (HP:0003010) | 3.14925809 |
| 35 | Periodontitis (HP:0000704) | 3.12608429 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.10555863 |
| 37 | IgM deficiency (HP:0002850) | 3.09997886 |
| 38 | Interstitial pulmonary disease (HP:0006530) | 3.05575289 |
| 39 | Hematochezia (HP:0002573) | 3.05538060 |
| 40 | Anorexia (HP:0002039) | 3.04189816 |
| 41 | Chronic otitis media (HP:0000389) | 3.01187544 |
| 42 | Thrombocytosis (HP:0001894) | 2.95480855 |
| 43 | Petechiae (HP:0000967) | 2.94479341 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94250295 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94250295 |
| 46 | Recurrent viral infections (HP:0004429) | 2.83424109 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.82191035 |
| 48 | Epistaxis (HP:0000421) | 2.81746294 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80284671 |
| 50 | T lymphocytopenia (HP:0005403) | 2.73675406 |
| 51 | Leukocytosis (HP:0001974) | 2.73634938 |
| 52 | Gastrointestinal inflammation (HP:0004386) | 2.69610490 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.68251758 |
| 54 | Vasculitis (HP:0002633) | 2.64672899 |
| 55 | Abnormal platelet function (HP:0011869) | 2.59763839 |
| 56 | Impaired platelet aggregation (HP:0003540) | 2.59763839 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.57863845 |
| 58 | Abnormality of the pleura (HP:0002103) | 2.57795041 |
| 59 | Colitis (HP:0002583) | 2.57774712 |
| 60 | Increased IgM level (HP:0003496) | 2.55584578 |
| 61 | Eosinophilia (HP:0001880) | 2.55017760 |
| 62 | Mucopolysacchariduria (HP:0008155) | 2.55005665 |
| 63 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.55005665 |
| 64 | Abnormality of T cells (HP:0002843) | 2.54710101 |
| 65 | Abnormality of the peritoneum (HP:0002585) | 2.54445573 |
| 66 | Retrobulbar optic neuritis (HP:0100654) | 2.53816242 |
| 67 | Optic neuritis (HP:0100653) | 2.53816242 |
| 68 | Pustule (HP:0200039) | 2.53010519 |
| 69 | Gingival bleeding (HP:0000225) | 2.52040054 |
| 70 | Thoracic kyphosis (HP:0002942) | 2.51294754 |
| 71 | Gangrene (HP:0100758) | 2.49282508 |
| 72 | Urethral obstruction (HP:0000796) | 2.49094675 |
| 73 | Microcytic anemia (HP:0001935) | 2.49055009 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44406897 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44406897 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44406897 |
| 77 | Osteomyelitis (HP:0002754) | 2.40574979 |
| 78 | Agnosia (HP:0010524) | 2.40310023 |
| 79 | Granulocytopenia (HP:0001913) | 2.39876619 |
| 80 | Abnormality of the endocardium (HP:0004306) | 2.37018096 |
| 81 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.35564047 |
| 82 | Hemoptysis (HP:0002105) | 2.33291905 |
| 83 | Autoimmune thrombocytopenia (HP:0001973) | 2.32943077 |
| 84 | Chest pain (HP:0100749) | 2.32502200 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.31206417 |
| 86 | Cheilitis (HP:0100825) | 2.25463958 |
| 87 | Glomerulopathy (HP:0100820) | 2.24403322 |
| 88 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.21513356 |
| 89 | Skin ulcer (HP:0200042) | 2.20066596 |
| 90 | Acute hepatic failure (HP:0006554) | 2.19450160 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.19124205 |
| 92 | Keratitis (HP:0000491) | 2.19081633 |
| 93 | Recurrent pneumonia (HP:0006532) | 2.18357497 |
| 94 | Acne (HP:0001061) | 2.17935744 |
| 95 | Axonal loss (HP:0003447) | 2.16972494 |
| 96 | Arterial thrombosis (HP:0004420) | 2.16367332 |
| 97 | Nephritis (HP:0000123) | 2.15688979 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.13621093 |
| 99 | Complement deficiency (HP:0004431) | 2.12735577 |
| 100 | Increased IgE level (HP:0003212) | 2.11848841 |
| 101 | Abnormality of the pericardium (HP:0001697) | 2.11753771 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.11119449 |
| 103 | Basal ganglia calcification (HP:0002135) | 2.10477747 |
| 104 | Vertigo (HP:0002321) | 2.06882976 |
| 105 | Disinhibition (HP:0000734) | 2.04534464 |
| 106 | Abnormality of T cell physiology (HP:0011840) | 2.03645156 |
| 107 | Pulmonary infiltrates (HP:0002113) | 2.03374213 |
| 108 | Metaphyseal cupping (HP:0003021) | 2.02741293 |
| 109 | Albinism (HP:0001022) | 2.02182950 |
| 110 | Loss of speech (HP:0002371) | 2.01514759 |
| 111 | Encephalitis (HP:0002383) | 2.00123768 |
| 112 | Subacute progressive viral hepatitis (HP:0006572) | 1.99418329 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99367868 |
| 114 | Sepsis (HP:0100806) | 1.99343244 |
| 115 | Slow saccadic eye movements (HP:0000514) | 1.98436312 |
| 116 | Keratoconjunctivitis sicca (HP:0001097) | 1.98322418 |
| 117 | Abnormality of the thoracic spine (HP:0100711) | 1.98126160 |
| 118 | Viral hepatitis (HP:0006562) | 1.96724220 |
| 119 | Abnormal platelet volume (HP:0011876) | 1.95080678 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.94803594 |
| 121 | Spondylolisthesis (HP:0003302) | 1.94012337 |
| 122 | Abnormality of the nasal mucosa (HP:0000433) | 1.93219801 |
| 123 | Hypermelanotic macule (HP:0001034) | 1.92184371 |
| 124 | Abnormality of complement system (HP:0005339) | 1.91138138 |
| 125 | Purpura (HP:0000979) | 1.90851150 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90161078 |
| 127 | Skin rash (HP:0000988) | 1.89869213 |
| 128 | Difficulty running (HP:0009046) | 1.89666146 |
| 129 | Amyloidosis (HP:0011034) | 1.86465836 |
| 130 | Recurrent lower respiratory tract infections (HP:0002783) | 1.86264290 |
| 131 | Pulmonary embolism (HP:0002204) | 1.85758554 |
| 132 | Acute myeloid leukemia (HP:0004808) | 1.85172923 |
| 133 | Short femoral neck (HP:0100864) | 1.85029777 |
| 134 | Increased serum ferritin (HP:0003281) | 1.84344409 |
| 135 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.83100744 |
| 136 | Polyneuropathy (HP:0001271) | 1.82142958 |
| 137 | Thyroiditis (HP:0100646) | 1.80316423 |
| 138 | Abnormality of iron homeostasis (HP:0011031) | 1.79975409 |
| 139 | Lymphopenia (HP:0001888) | 1.79651885 |
| 140 | Polygenic inheritance (HP:0010982) | 1.79598805 |
| 141 | Thrombophlebitis (HP:0004418) | 1.75844762 |
| 142 | Nasal polyposis (HP:0100582) | 1.72741204 |
| 143 | Recurrent sinusitis (HP:0011108) | 1.71846281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.05451072 |
| 2 | TGFBR2 | 3.61660924 |
| 3 | KIT | 3.18500859 |
| 4 | MAP4K1 | 3.05497845 |
| 5 | MAP2K3 | 3.01707716 |
| 6 | RIPK4 | 2.94242175 |
| 7 | BLK | 2.83496545 |
| 8 | ERN1 | 2.82919840 |
| 9 | CSF1R | 2.71017574 |
| 10 | BTK | 2.64423892 |
| 11 | TEC | 2.62115029 |
| 12 | EPHB1 | 2.61694274 |
| 13 | FES | 2.45051256 |
| 14 | TYK2 | 2.16520452 |
| 15 | IRAK3 | 2.04266082 |
| 16 | CLK1 | 2.01947862 |
| 17 | ZAP70 | 1.97270635 |
| 18 | CSK | 1.85787570 |
| 19 | PAK4 | 1.78294824 |
| 20 | PRPF4B | 1.78099594 |
| 21 | FLT3 | 1.76442713 |
| 22 | STK10 | 1.73093581 |
| 23 | TXK | 1.65910573 |
| 24 | TBK1 | 1.63568411 |
| 25 | KSR2 | 1.55297962 |
| 26 | MAP3K3 | 1.55114063 |
| 27 | TRPM7 | 1.50142034 |
| 28 | * HCK | 1.47000864 |
| 29 | SIK3 | 1.46140231 |
| 30 | CAMK1D | 1.45803172 |
| 31 | SYK | 1.39995158 |
| 32 | MATK | 1.37223879 |
| 33 | ITK | 1.34469959 |
| 34 | MAP3K1 | 1.30263655 |
| 35 | IRAK1 | 1.26778342 |
| 36 | FGR | 1.23380857 |
| 37 | IRAK2 | 1.17045296 |
| 38 | MARK2 | 1.16831053 |
| 39 | LYN | 1.15626626 |
| 40 | GRK7 | 1.14404086 |
| 41 | MAP3K12 | 1.13535913 |
| 42 | PRKD2 | 1.12620882 |
| 43 | LCK | 1.07971378 |
| 44 | GRK6 | 1.03591174 |
| 45 | EEF2K | 1.03445903 |
| 46 | CAMK1G | 1.02695718 |
| 47 | IKBKE | 1.02211870 |
| 48 | TAOK3 | 1.00183569 |
| 49 | CDK19 | 0.96991394 |
| 50 | MAP3K14 | 0.94435034 |
| 51 | JAK3 | 0.92409529 |
| 52 | IKBKB | 0.91709488 |
| 53 | RPS6KA4 | 0.91679704 |
| 54 | CAMKK2 | 0.91533215 |
| 55 | PKN2 | 0.90508686 |
| 56 | SMG1 | 0.90211408 |
| 57 | LRRK2 | 0.89405259 |
| 58 | TRIB3 | 0.88567389 |
| 59 | PRKG2 | 0.85071675 |
| 60 | MAP3K7 | 0.82126167 |
| 61 | MAP2K4 | 0.80065871 |
| 62 | PTK6 | 0.79665024 |
| 63 | MAP3K11 | 0.76625824 |
| 64 | TAOK2 | 0.76458566 |
| 65 | PTK2B | 0.73409131 |
| 66 | JAK1 | 0.72519479 |
| 67 | MAP3K2 | 0.71468874 |
| 68 | FYN | 0.69903846 |
| 69 | STK38 | 0.69174276 |
| 70 | STK11 | 0.68589767 |
| 71 | DYRK1B | 0.68378197 |
| 72 | BMPR2 | 0.65450082 |
| 73 | PIK3CG | 0.65445295 |
| 74 | PIM1 | 0.65076442 |
| 75 | SIK2 | 0.65052570 |
| 76 | EPHA3 | 0.64437942 |
| 77 | JAK2 | 0.63195783 |
| 78 | ERBB3 | 0.63075745 |
| 79 | DAPK2 | 0.61767571 |
| 80 | MAPK15 | 0.61270504 |
| 81 | RAF1 | 0.61033241 |
| 82 | MARK3 | 0.60898396 |
| 83 | RPS6KA6 | 0.60554317 |
| 84 | MAPKAPK2 | 0.60344404 |
| 85 | VRK1 | 0.59692254 |
| 86 | TGFBR1 | 0.58750975 |
| 87 | MAPK4 | 0.57029387 |
| 88 | TAOK1 | 0.56610115 |
| 89 | SIK1 | 0.56014113 |
| 90 | MAP3K5 | 0.55779215 |
| 91 | RPS6KL1 | 0.54650591 |
| 92 | RPS6KC1 | 0.54650591 |
| 93 | YES1 | 0.53489087 |
| 94 | KSR1 | 0.52460504 |
| 95 | MAP3K6 | 0.52094278 |
| 96 | MAP3K13 | 0.50578132 |
| 97 | TNK2 | 0.50091636 |
| 98 | PRKCQ | 0.49769588 |
| 99 | HIPK2 | 0.49521230 |
| 100 | RET | 0.49359510 |
| 101 | MAP3K9 | 0.49298369 |
| 102 | EGFR | 0.49278231 |
| 103 | CDC42BPA | 0.48423987 |
| 104 | ALK | 0.48354314 |
| 105 | TSSK6 | 0.48227957 |
| 106 | NEK2 | 0.46668555 |
| 107 | TESK2 | 0.46289948 |
| 108 | FGFR4 | 0.46034255 |
| 109 | FGFR3 | 0.45236006 |
| 110 | PRKCD | 0.45137516 |
| 111 | MAPK7 | 0.43856256 |
| 112 | KDR | 0.42105046 |
| 113 | CAMK4 | 0.41652215 |
| 114 | PIM2 | 0.41408499 |
| 115 | PRKCZ | 0.41265455 |
| 116 | PDK1 | 0.41025821 |
| 117 | NLK | 0.40432385 |
| 118 | RPS6KA2 | 0.38141505 |
| 119 | MAP3K8 | 0.37486271 |
| 120 | MAPKAPK3 | 0.36981487 |
| 121 | PDPK1 | 0.36424107 |
| 122 | NEK9 | 0.35763952 |
| 123 | EIF2AK2 | 0.34867522 |
| 124 | MAPK12 | 0.34796191 |
| 125 | PRKAA2 | 0.33223786 |
| 126 | STK4 | 0.33185312 |
| 127 | CAMKK1 | 0.32383955 |
| 128 | CAMK1 | 0.32238215 |
| 129 | PTK2 | 0.32202869 |
| 130 | MAP2K6 | 0.32177883 |
| 131 | WNK1 | 0.31288111 |
| 132 | ADRBK2 | 0.31131441 |
| 133 | SGK3 | 0.30977923 |
| 134 | SGK2 | 0.29944409 |
| 135 | PRKCH | 0.29000476 |
| 136 | STK16 | 0.28805774 |
| 137 | ABL1 | 0.27399188 |
| 138 | CDK7 | 0.26508723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.19836466 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.53273143 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92342793 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75314906 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.73356609 |
| 6 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.33421441 |
| 7 | Pertussis_Homo sapiens_hsa05133 | 2.32427493 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.31992668 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24095382 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.04911503 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03130184 |
| 12 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.96809448 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.87788298 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.87352535 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87199936 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.85575710 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.74579626 |
| 18 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.74128787 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72445261 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.71461756 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69823114 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63473975 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62425877 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.59032459 |
| 25 | Shigellosis_Homo sapiens_hsa05131 | 1.58767779 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.56302527 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55687068 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55639855 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.54235907 |
| 30 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.50160748 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.43635885 |
| 32 | Platelet activation_Homo sapiens_hsa04611 | 1.40623825 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40227735 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35442146 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.32865344 |
| 36 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29034078 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.28874213 |
| 38 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.27264875 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.26135817 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25260127 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.25045741 |
| 42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17966281 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.17078561 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.09450508 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09428692 |
| 46 | Phagosome_Homo sapiens_hsa04145 | 1.08786145 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08069107 |
| 48 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.04352539 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01233180 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96881527 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95373776 |
| 52 | Apoptosis_Homo sapiens_hsa04210 | 0.93471563 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.93266719 |
| 54 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.91879251 |
| 55 | DNA replication_Homo sapiens_hsa03030 | 0.89937721 |
| 56 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88202905 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83751157 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83444863 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81710880 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79113076 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78341821 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78286177 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.78221889 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77907480 |
| 65 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75317073 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73454908 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71781299 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70898858 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70817864 |
| 70 | Hepatitis C_Homo sapiens_hsa05160 | 0.69143088 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68978089 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68584519 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68505176 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.67586994 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67427329 |
| 76 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65478552 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63534897 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.63173721 |
| 79 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63151460 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.62512877 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61339224 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59779404 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59012413 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58441100 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57104513 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54742175 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.54663729 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52666274 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.51843479 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.51249458 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50996051 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49595389 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49371297 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47706436 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.47339920 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.47126448 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.45606141 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45234543 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44020188 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43161678 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40888999 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38729737 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36551994 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36351457 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.36309717 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35529757 |
| 107 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34821801 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.34278111 |
| 109 | Allograft rejection_Homo sapiens_hsa05330 | 0.33137725 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.31503242 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31424692 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30858679 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30675961 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.29410315 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29238410 |
| 116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.28577277 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28135920 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27343892 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26425194 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26110457 |

